COH +9%: A stronger than expected sect of 1H22 results from the hearing implant company today driving the share price sharply higher. While there has been intermittent restrictions impacting operating conditions around the world, Cochlear have still managed to grow both revenue and margins, particularly in developed markets, with a surprise fall in operating expenses. Guidance was maintained for the full year, looking for net profit of $265-285m however it now includes COVID costs and cloud computing expenses, so really around a 5% increase to what the market had pencilled in.
scroll
Question asked
Question asked
Question asked
Question asked
Question asked
Gerrish: The correction is done, we’re positioning for what comes next
Close
A discussion with Geoff Wilson – Wilson Asset Management & James Gerrish – Market Matters
Close
Friday 9th May – Dow up +254pts, SPI up +3pts
Close
Related Q&A
Shares COHLEAR , SILVER MINES LIMITED, VYSARN LIMITED
COH and Emerging Companies portfolio performance
Cochlear (COH)
What are MM’s favoured recession proof Healthcare stocks?
MVF, COH, MQG & TWE
Relevant suggested news and content from the site

Video
WATCH
Gerrish: The correction is done, we’re positioning for what comes next
The Market Matters lead portfolio manager talks the recent recovery, Trump, gold, and why he thinks there's plenty of opportunities.

Video
WATCH
A discussion with Geoff Wilson – Wilson Asset Management & James Gerrish – Market Matters
Recorded Monday 31st March

Podcast
LISTEN
Friday 9th May – Dow up +254pts, SPI up +3pts
Daily Podcast Direct from the Desk
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.